China’s Therapeutic mRNA Vaccine Pipeline For Oncology The Largest Globally

Multiple Candidates Despite Relatively Small Market

 
• By Xu Hu
  
mRNA vaccines
Chinese companies have highest number of mRNA-based therapeutic vaccines in development for cancer globally (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from China